Psyence Biomedical (PBM) Stock Statistics & Valuation Metrics

Psyence Biomedical has a market cap or net worth of $1.44M. The enterprise value is $66.08B.

Psyence Biomedical has 1,872,051 shares outstanding. The number of shares has decreased by -2.65% in one year.

Psyence Biomedical’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is 0.00%.

The current PE Ratio of Psyence Biomedical is ―. Psyence Biomedical’s PEG ratio is 0.00.

In the last 12 months, Psyence Biomedical had revenue of 0.00 and earned 1.01M in profits. Earnings per share was 1.78.

In the last 12 months, operating cash flow was -1.05M and capital expenditures 0.00, giving a free cash flow of -802.31K billion.

Psyence Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Psyence Biomedical upcoming earnings date is ―, ―.

Psyence Biomedical as a current ratio of 11.04, with Debt / Equity ratio of 0.00%

In the past 12 months, Psyence Biomedical has paid 0.00 in taxes.

Psyence Biomedical EV to EBITDA ratio is 0.00, with an EV/FCF ratio of 1.64.

Psyence Biomedical has $0.00 in cash and marketable securities with $10.45K in debt, giving a net cash position of -$10.45K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Psyence Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―